Renal Cell Carcinoma Clinical Trials
Renal Cell Carcinoma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for renal Cell Carcinoma. Corterve aggregates actively recruiting Renal Cell Carcinoma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Renal Cell Carcinoma studies
- Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell CarcinomaNCT07564232PHASE1M.D. Anderson Cancer CenterHouston, Texas
- Sitagliptin With Pembro in RCC and MelanomaNCT07634380PHASE1Fernando Maciel BarbosaIowa City, Iowa
- Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON TrialNCT06866262PHASE1, PHASE2University of Michigan Rogel Cancer CenterAnn Arbor, Michigan
- A Phase I Study of SIM0505 in Participants With Advanced Solid TumorsNCT06792552PHASE1NextCure, Inc.Orlando, Florida
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)NCT04198766PHASE1, PHASE2Inhibrx Biosciences, IncDuarte, California
- Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine TumorsNCT05263050PHASE2Fox Chase Cancer CenterPhiladelphia, Pennsylvania
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)NCT07293351PHASE1, PHASE2Bristol-Myers SquibbPalo Alto, California
- Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)NCT05665361PHASE1, PHASE2National Cancer Institute (NCI)Bethesda, Maryland
- A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid TumorsNCT05536141PHASE1Arcus Biosciences, Inc.Birmingham, Alabama
- Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsNCT03866382PHASE2National Cancer Institute (NCI)Birmingham, Alabama
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasNCT07285044PHASE2Mayo ClinicJacksonville, Florida
- A Phase 1 Study of the Safety and Tolerability of CTX-10726NCT07419841PHASE1Compass TherapeuticsOmaha, Nebraska
Renal Cell Carcinoma trials by state
Renal Cell Carcinoma trials by metro
Frequently asked questions
- How do I find recruiting Renal Cell Carcinoma clinical trials?
- Corterve aggregates actively recruiting Renal Cell Carcinoma studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Renal Cell Carcinoma clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Renal Cell Carcinoma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.